AACR logo

More articles from Poster Presentations - Late-Breaking Abstracts

Abstract LB-17: Oral delivery of taurocholic acid-linked heparin-docetaxel conjugates for tumor and its angiogenesis therapy
Zehedina Khatun, MD Nurunnabi, Kang Moo Huh, Yong-kyu Lee

Cancer Research Oct 2014, 74 (19 Supplement) LB-17; DOI: 10.1158/1538-7445.AM2014-LB-17
Abstract LB-13: Hyaluronic acid-based CD44 targeted nanoparticle delivery of combination MDR1 siRNA/paclitaxel to overcome drug resistance in ovarian cancer
Xiaoqian Yang, Arun lyer, Francis hornicek, Mansoor Amiji, Zhenfeng Duan

Cancer Research Oct 2014, 74 (19 Supplement) LB-13; DOI: 10.1158/1538-7445.AM2014-LB-13
Abstract LB-16: Discovery of novel SGK1 inhibitors by a fragment-based approach: Generating patentable, chemically tractable and ligand efficient leads
Gordon Alton, Warren Wade, Laura Lingardo, Ayse Batova, Tom Smart, Chris Buhr, James W. Zapf, Peter Pallai

Cancer Research Oct 2014, 74 (19 Supplement) LB-16; DOI: 10.1158/1538-7445.AM2014-LB-16
Abstract LB-25: CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting p53-dependent signaling pathway
Qichao Huang, Jibin Li, Jinliang Xing

Cancer Research Oct 2014, 74 (19 Supplement) LB-25; DOI: 10.1158/1538-7445.AM2014-LB-25
Abstract LB-5: Ultraviolet radiation inhibits murine mammary carcinogenesis at an early stage
Anastasia M. Makarova, Grace Wang, Eileen Libove, Yefim Khaimskiy, Ervin H. Epstein

Cancer Research Oct 2014, 74 (19 Supplement) LB-5; DOI: 10.1158/1538-7445.AM2014-LB-5
Abstract LB-29: Disruption of annexin II tetramer/receptor axis suppresses leukemia cell homing and engraftment
Gopalakrishnapillai Anilkumar, Priyanka Dhanan, Edward A. Kolb, Andrew Napper, Robert Mason, Sonali P. Barwe

Cancer Research Oct 2014, 74 (19 Supplement) LB-29; DOI: 10.1158/1538-7445.AM2014-LB-29
Abstract LB-34: 3-Dimensional air-liquid interface organoid culture of primary human tumor biopsies
James T. Neal, Michael Cantrell, Paul Rack, Calvin J. Kuo

Cancer Research Oct 2014, 74 (19 Supplement) LB-34; DOI: 10.1158/1538-7445.AM2014-LB-34
Abstract LB-3: Apolipoprotein (E) is a determinant of colon carcinogenesis potentially by regulating inflammation and β-catenin independently of its role in lipid metabolism
Ali I. Elbahrawy, Abdelmetalab Tarhuni, Amarjit S. Naura, Youssef Errami, Mohamed Alwan, Samar Hammad, Jimena Trillo-Tinoco, Ramadan Hemeida, Hassan Brim, Hassan Ashktorab, Luis Del Valle, Hamid A. Boulares

Cancer Research Oct 2014, 74 (19 Supplement) LB-3; DOI: 10.1158/1538-7445.AM2014-LB-3
Abstract CT420: An open label pilot study of NovoTTF Therapy concomitant with gemcitabine for front-line therapy of advanced pancreatic adenocarcinoma (NCT01971281)
Uri Weinberg, Eilon D. Kirson, Ori Farber, Moshe Giladi, Yoram Palti

Cancer Research Oct 2014, 74 (19 Supplement) CT420; DOI: 10.1158/1538-7445.AM2014-CT420
Abstract LB-35: Living biobank of cancer organoids for drug development and screening
Robert G.J. Vries, Hans Clevers

Cancer Research Oct 2014, 74 (19 Supplement) LB-35; DOI: 10.1158/1538-7445.AM2014-LB-35

Main menu

User menu

Search

More articles from Poster Presentations - Late-Breaking Abstracts

Pages

Articles

Info for

About Cancer Research